Literature DB >> 28741096

Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a "quasi-continuum" gradient of antibiotic concentrations.

R Falcón1, E M Mateo1, A Talaya1, E Giménez1, V Vinuesa1, M Á Clari2, D Navarro3,4.   

Abstract

The availability of reproducible broth microdilution (BMD) methods including inter log2 antibiotic dilutions for measuring Staphylococcus aureus (SA) vancomycin minimum inhibitory concentrations (MICs) within the susceptible range is needed to elucidate the impact of vancomycin MICs on clinical outcomes of invasive SA infections. Here, we report on the development of a very precise BMD method that incorporates the following incremental antibiotic concentrations: 0.50, 0.62, 0.75, 0.87, 1.0, 1.25, 1.40, 1.50, 1.60, 1.75, and 2.0 μg/mL. The intra- and inter-assay coefficients of variation of this method were around 20%. The mean of the differences in MIC values for all isolates obtained across two independent runs performed at one center was 0.04 μg/mL [95% confidence interval (CI), 0.011-0.07 μg/mL] and that for ten isolates measured at two different centers was 0.04 μg/mL (95% CI, 0-13 μg/mL). Vancomycin MIC values differed by less than 0.1 μg/mL between runs for most isolates. Storage of isolates at -20 °C for up to 3 months had no impact on the vancomycin MIC values. The mean vancomycin MIC values obtained by the Etest using a standard inoculum (0.5 McFarland) were significantly higher (p ≤ 0.001) than those measured by BMD and the MIC values measured by the two methods correlated poorly (Rho, 0.319; p = 0.148). Nevertheless, the mean MIC values measured by the Etest using lower inocula (107 or 106 CFU/mL) and those measured by BMD were comparable and correlated significantly (p = 0.004 for 107 CFU/mL and p = 0.029 for 106 CFU/mL).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28741096     DOI: 10.1007/s10096-017-3067-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Use of coefficient of variation in assessing variability of quantitative assays.

Authors:  George F Reed; Freyja Lynn; Bruce D Meade
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 2.  The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

Authors:  S J van Hal; T P Lodise; D L Paterson
Journal:  Clin Infect Dis       Date:  2012-02-02       Impact factor: 9.079

3.  Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.

Authors:  Beatriz Muñoz-Cobo; Silvia Sancho-Tello; Elisa Costa; Dayana Bravo; Isidro Torregrosa; Juan García de Lomas; David Navarro
Journal:  Int J Antimicrob Agents       Date:  2011-01-26       Impact factor: 5.283

4.  Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates.

Authors:  Rocío Falcón; Silvia Madrid; Nuria Tormo; Cristina Casañ; Eliseo Albert; Concepción Gimeno; David Navarro
Journal:  Clin Infect Dis       Date:  2015-07-17       Impact factor: 9.079

5.  Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Franziska Ludwig; Becky Edwards; Timothy Lawes; Ian M Gould
Journal:  J Clin Microbiol       Date:  2012-08-01       Impact factor: 5.948

6.  Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods.

Authors:  Michael J Rybak; Celine Vidaillac; Helio S Sader; Paul R Rhomberg; Hossein Salimnia; Lawrence E Briski; Audrey Wanger; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

7.  Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.

Authors:  Nina J Hos; Nathalie Jazmati; Danuta Stefanik; Martin Hellmich; Halil AlSael; Winfried V Kern; Siegbert Rieg; Hilmar Wisplinghoff; Harald Seifert; Achim J Kaasch
Journal:  J Infect       Date:  2016-12-22       Impact factor: 6.072

Review 8.  Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

Authors:  Andre C Kalil; Trevor C Van Schooneveld; Paul D Fey; Mark E Rupp
Journal:  JAMA       Date:  2014-10-15       Impact factor: 56.272

9.  Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006.

Authors:  Marta Rodríguez-Créixems; Luis Alcalá; Patricia Muñoz; Emilia Cercenado; Teresa Vicente; Emilio Bouza
Journal:  Medicine (Baltimore)       Date:  2008-07       Impact factor: 1.889

10.  High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

Authors:  Jesse T Jacob; Carlos A DiazGranados
Journal:  Int J Infect Dis       Date:  2012-10-22       Impact factor: 3.623

View more
  1 in total

1.  Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.

Authors:  Rocío Falcón; Eva Mateo; Rosa Oltra; Estela Giménez; Eliseo Albert; Ignacio Torres; David Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-06       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.